High VWAP Low; 0.19: 0.1714: 0.16: 1d. delayed. High VWAP Low; 0.16 ... Average vol. Get CEO.CA Pro. Pharmadrug Inc. BUZZ.CN 15 min. Market depth is not enabled for CSE. Not a recommendation to buy or sell. High VWAP Low; 0.19: 0.1714: 0.16: 1d. This forward-looking information consists of disclosure regarding possible events, conditions or results, and is based on numerous assumptions, including that Pharmadrug will be able to successfully develop and execute its plans for international growth, that Israel will permit the export of medical cannabis, and that certain jurisdictions in Europe will permit the importation of medical cannabis. 2021-02-02 11:37 ET - News Release. Real-time discussion about Pharmadrug Inc. (BUZZ.CN) on CEO.CA, an investment chat community for Canada's small cap markets Market depth is not enabled for CSE. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. Last updated 15:59 PM Market Depth. Pharmadrug Inc. BUZZ.CN 15 min. PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer . Stock Info & News; Financials; Management Presentation; Contact (416) 201-2840. Pharmadrug Inc. BUZZ.CN 15 min. delayed Enable Real-Time • Volume Bids Asks CSE ATS. Market depth is not enabled for CSE. You further agree to indemnify and save harmless Pharmadrug and the foregoing personnel from any damages, losses, costs, expenses or claims arising from your breach of these Terms. If you do not agree to these Terms, then you must not access the Site. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. High VWAP Low; 0.175: 0.1625: 0.14: 1d. Get CEO.CA Pro to gain access. News release - English - Pharmadrug Inc. 77 King Street West, Suite 2905, Toronto, ON M5K 1H1. Get CEO.CA Pro to gain access. Get CEO.CA Pro to gain access. delayed. Last updated 11:29 AM Market Depth. PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. About PharmaDrug Inc. PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. Last updated 2021/03/04 15:59 PM Market Depth. Last updated 2021/02/16 16:28 PM Market Depth. You agree not to download, display, or use any content on the Site for any purposes or uses other than your personal information. Pharmadrug Inc. BUZZ.CN 15 min. You agree that your use of the Site is entirely at your own risk, and that under no circumstances whatsoever shall Pharmadrug or any of its directors, officers, employees, consultants, agents or representatives be liable for any damages, losses, costs, expenses or claims of any kind which may arise, directly or indirectly, through or as a result of your access to, inability to access, or use of this Site. High VWAP Low; 0.16 ... Average vol. Tetra Bio-Pharma Inc. (" Tetra Bio-Pharma " or the " Company ") (TSX: TBP) (OTCQB: TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development, is pleased to announce that is has entered into an agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. (together, the " Underwriters ") pursuant to which the Underwriters have agreed to purchase, on a … Tier One Silver Inc. (formerly, Tier One Metals Inc.) Mar 2 2021 19:15:40 ET News release - English. This Site and certain materials made available on it contain “forward-looking information” within the meaning of Canadian securities laws. About Pharmadrug Inc. Pharmadrug is a specialty pharmaceutical company focused on the development and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally derived approved drugs. Get CEO.CA Pro to gain access. Toronto, Ontario--(Newsfile Corp. - February 5, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") announces the grant of stock options to directors, officers and consultants to purchase 5,200,000 common shares of the Company, exercisable at $0.085 per share at any time on or before February 4, 2026. Last updated 2021/02/17 15:59 PM Market Depth. delayed Enable Real-Time • Volume Bids Asks CSE ATS. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics … MARKETABLE SECURITIES Number of Unrealized Fair September 30, 2020 Shares Cost Loss Value PharmaDrug Inc. – common shares 12,000,000 510,000 (150,000) 360,000 PharmaDrug Inc. - warrants 12,000,000 390,000 (135,000) 255,000 In May 2020, Finco issued 2,500,000 subscription receipts to Revive Therapeutics Ltd. (“Revive”) valued at $0.06 each which were then converted into common … PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. Accordingly, Site visitors and investors should not place undue reliance on such forward-looking information. Market Depth Chart Tables 15 min. PDF 225 K TILT Holdings Inc. Mar 2 2021 07:20:04 ET News release - … Pharmadrug Inc.: PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc. PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC. WHO RECENTLY RECEIVED ORPHAN DRUG DESIGNATION FROM FDA FOR ESOPHAGEAL CANCER. Pharmadrug Inc. has entered into the definitive agreement in respect of the previously announced (see press release dated Jan. 12, 2021) proposed acquisition of Sairiyo Therapeutics Inc. on Jan. 12, 2021. delayed. Always do additional research and consult a professional before purchasing a security. The author holds no licenses. PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC. Pharmadrug Inc. has completed the previously announced (see press releases dated Jan. 12, 2021, and Jan. 25, 2021) acquisition of Sairiyo Therapeutics Inc. on Feb. 2, 2021. High VWAP Low; 0.135: 0.1102: 0.10: 1d. Filed on: 03-04-2021. Tetra Bio-Pharma Inc. (" Tetra Bio-Pharma " or the " Company ") (TSX: TBP) (OTCQB: TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development, is pleased to announce that is has entered into an agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. (together, the " Underwriters ") pursuant to which the Underwriters have agreed to purchase, on a … InvestorX SEDAR® Issuer number: 00032549. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics … SEDI Insider filings House positions SEDAR Documents Community Wiki Website. Market depth is not enabled for CSE. Mr. Daniel Cohen reports. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. Item 4. Project number: 03172193. Get CEO.CA Pro to gain access. Market Depth Chart Tables 15 min. The Company also owns 100% of Super Smart, a Dutch company building a modern adult use psychedelic retail business with an elevated and educational focus. Forward-looking information on this Site from time to time may include, without limitation, statements regarding the Company’s strategic plans and objectives, proposed jurisdictions for business expansion, economic potential of cannabis investments, and other matters disclosed in Pharmadrug’s continuous disclosure documents available under our profile on www.sedar.com. 0.135 0.01 ... Average vol. Pharmadrug Inc. BUZZ.CN 15 min. Pharmadrug makes no representation that the Site or its content is appropriate or available for use in locations outside Canada or for minors. Always do additional research and consult a professional before purchasing a security. delayed. If any provision in these Terms shall be found to be void or unenforceable for any reason, that provision shall not affect the validity and enforceability of any remaining provisions. Although we try to keep the information on the Site current and accurate, we make no warranties or representations as to its accuracy. The shares will begin trading under the new name on October 22, 2019. The Company also owns 100% of Super Smart, a Dutch company building a modern adult use psychedelic retail business with an elevated and educational focus. FSD PHARMA INC. FORM 51-102F3 ... referred to in this report was issued by the Corporation and disseminated on June 3, 2020 through Cision and filed on SEDAR at www.sedar.com under the Corporation's profile. This Site and its content have been prepared by Pharmadrug for informational purposes only. The Company owns 80% of PharmaDrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. High VWAP Low; 0.16 ... Average vol. 1w. SEDAR® Public Document. delayed Enable Real-Time • Volume Bids Asks CSE ATS. Toronto, Ontario–(Newsfile Corp. – May 25, 2020) – Pharmadrug Inc. (CSE: BUZZ) (OTC: LMLLF) (“Pharmadrug” or the “Company”) is pleased to announce that it has entered into a definitive agreement (the “Acquisition Agreement”) pursuant to which Pharmadrug will acquire all of the issued and outstanding shares of privately-held Interrobang Ltd. (doing business as Super Smart). SEDI Insider filings House positions SEDAR Documents Community Wiki Website. 1w ... Average vol. Market depth is not enabled for CSE. Jay Lutz. Market depth is only available on TSX & TSXV stocks Market Depth. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. Summary of Material Change On June 3, 2020, the Corporation announced that the U.S. Food and Drug Administration ("FDA") has granted the Corporation permission to submit … Market Depth Chart Tables 15 min. Last updated 2021/02/19 15:59 PM Market Depth. This Site is only intended for use by persons who are located within Canada and who are of the legal age of majority in the province from which they access this Site. delayed. Get CEO.CA Pro to gain access. Disclosure documents are available at www.thecse.com. Get CEO.CA Pro to gain access. Not a recommendation to buy or sell. Not a recommendation to buy or sell. PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer. Get CEO.CA Pro to gain access. Project number: 03182797. Leadership in … Pharmadrug Inc. has granted stock options to directors, officers and consultants to purchase 5.2 million common shares of the company, exercisable at 8.5 cents per share at any time on or before Feb. 4, 2026. InvestorX SEDAR® Issuer number: 00032549. delayed. This Site is not intended to assist you in violating any federal laws. Pharmadrug closes acquisition of Sairiyo. 1m ... Average vol. The author holds no licenses. Information for this briefing was found via Sedar and Red Light Holland. Get CEO.CA Pro to gain access. Last updated 2021/03/01 15:59 PM Market Depth. Project number: 03178123. delayed. Document type: News release - English. Management of the company believes that the proposed acquisition will strengthen Pharmadrug's product pipeline, intellectual property portfolio and pharmaceutical development expertise. Market depth is not enabled for CSE. Toronto, Ontario--(Newsfile Corp. - February 5, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") announces the grant of stock options to directors, officers and consultants to purchase 5,200,000 common shares of the Company, exercisable at $0.085 per share at any time on or before February 4, 2026. The grants are subject to the terms of the company's stock option plan. Access securities related information for Canadian companies. Market depth is not enabled for CSE. In the first Alantra Pharma Fast 50, the constituent companies’ combined revenues totalled £2.3 billion; in 2021, this figure has risen to £3.1 billion – a near 35% jump. Last updated 2021/03/01 15:59 PM Market Depth. Real-time Level 2 Market Depth. E-MAIL NOW. Market depth is not enabled for CSE. 0.15 0.0%. Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. About PharmaDrug Inc. PharmaDrug Inc. is a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics … SEDI Insider filings House positions SEDAR Documents Community Wiki Website. About PharmaDrug Inc. PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. Get CEO.CA Pro. Document type: News release - English. Last updated 15:59 PM Market Depth. Dealers are reminded to re-enter their orders. Company name: Pharmadrug Inc. Get CEO.CA Pro to gain access. delayed Enable Real-Time • Volume Bids Asks CSE ATS. Market depth is only available on TSX & TSXV stocks Market Depth. PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC. PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC. WHO RECENTLY RECEIVED ORPHAN DRUG DESIGNATION FROM FDA FOR ESOPHAGEAL CANCER. Market depth is only available on TSX & TSXV stocks Market Depth. Jay Lutz. Market depth is not enabled for CSE. The grants are subject to the terms of the company's stock option plan. By visiting the Site you agree to be bound by these Website Terms of Use (the “Terms”). The industry’s growth is clear to see. About PharmaDrug Inc. PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. PharmaDrug Grants Stock Options. Pharmadrug Inc. BUZZ.CN 15 min. Get CEO.CA Pro to gain access. 0.15 0.0%. SEDAR® Public Document. Real-time Level 2 Market Depth. 1w. Information for this briefing was found via Sedar, Red Light Holland and Pharmadrug Inc. Pharmadrug Inc is a former client of Canacom Group, the parent company of The Deep Dive. Search SEDAR Filings. The common shares of Aura Health Inc., have been approved for listing on the CSE. Filed on: 02-11-2021. Market Depth Chart Tables 15 min. PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. Please read our Privacy Policy for more information about our information collection and use practices. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. About PharmaDrug Inc. PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. Generally, forward-looking information can be identified by words such as “plans”, “expects”, “scheduled”, “estimates”, “intends”, “anticipates”, or “believes”, or variations of such words indicating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken or occur. On certain areas of the Site, you may have the ability to provide us with personally identifiable information. Information for this briefing was found via Sedar and Red Light Holland. The Company owns 80% of PharmaDrug … The Company owns 80% of PharmaDrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. 0.155 0.02 11.4%. Toronto, Ontario--(Newsfile Corp. - December 15, 2020) - Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to provide an update to the status of its balance sheet following the recent general equity market upswing and the increase in PharmaDrug's volume and share price appreciation. Get CEO.CA Pro. Market depth is not enabled for CSE. Jay Lutz. Listing and disclosure documents will be available at www.thecse.com on the trading date. Pharmadrug Inc is a former client of Canacom Group, the parent company of The Deep Dive. Please note that all open orders will be cancelled at the end of business on October 21, 2019. PHARMADRUG; SUPERSMART; SAIRIYO; Investors. News release - English - Pharmadrug Inc. High VWAP Low; 0.175: 0.1559: 0.145: 1d. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. No warranties, express or implied, are made with respect to this Site or any information herein. Get CEO.CA Pro to gain access. TRYP Therapeutics is a pharmaceutical company focused on identifying and developing clinical-stage compounds for orphan diseases with high unmet medical needs. 1m ... Average vol. Last updated 2021/02/22 16:48 PM Market Depth. The author holds no licenses. 0.195 0.06 ... Average vol. PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. InvestorX SEDAR® Issuer number: 00032549. News release - English - Pharmadrug Inc. 1w ... Average vol. 0.175 0.015 9.4%. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics … 1m ... Average vol. Filing date: 02-11-2021. Forward-looking information on this Site from time to time may include, without limitation, statements regarding the Company’s strategic plans and objectives, proposed jurisdictions for business expansion, economic potential of cannabis investments, and other matters disclosed in Pharmadrug’s continuous disclosure documents available under our profile on www.sedar.com. As the founder of The Deep Dive, Jay is … Market depth is only available on TSX & TSXV stocks Market Depth. Market depth is not enabled for CSE. Real-time discussion about Pharmadrug Inc. (BUZZ.CN) on CEO.CA, an investment chat community for Canada's small cap markets PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. All content on this Site is the property of Pharmadrug and is protected by copyright and other intellectual property laws. Get CEO.CA Pro to gain access. 0.115 0.02 14.8%. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC. PHARMADRUG PROVIDES CORPORATE UPDATE AND BALANCE SHEET STATUS, PHARMADRUG SHORTLISTS PRIME AMSTERDAM LOCATIONS FOR STATE-OF-THE-ART SMART SHOP SUPERSTORE AND EXPANDS SCOPE OF E-COMMERCE PLATFORM WITH ESSENTIAL GOOD, 2019-1010 – Name Change - Aura Health Inc. (BUZZ), 2018-0812 – New Listing – Aura Health Inc. (BUZZ), Form 7 - Monthly Progress Report (February 2021), Form 7 - Monthly Progress Report (January 2021), Form 9 Proposed Issuance of Listed Securities, Form 7 - Monthly Progress Report (December 2020), Form 7 - Monthly Progress Report (November 2020), Form 5 - Quarterly Listing Statement (Q3 2020). Project number: 03182797. News release - English - Pharmadrug Inc. Last updated 2021/02/12 15:59 PM Market Depth. Mindset Pharma is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. Get CEO.CA Pro to gain access. 1w. Last updated 2021/02/23 15:59 PM Market Depth. Pharmadrug Inc. brings safe and affordable medical marijuana to end markets and add value to shareholders. © 2021 CNSX Markets Inc. All Rights Reserved, © 2021 CNSX Markets Inc. Tous droits Réservés, WORLD-RENOWNED GASTRIC CANCER EXPERT DR. YELENA Y. JANJIGIAN JOINS SAIRIYO THERAPEUTICS SCIENTIFIC AND CLINICAL ADVISORY BOARD, PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY, PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD FOR PSYCHEDELIC PHARMACEUTICALS, PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS AND BALANCE SHEET IMPROVEMENTS. (416) 201-2840 Email Now; About. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. The Company owns 80% of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC. Toronto, Ontario -- January 12, 2021 -- InvestorsHub NewsWire -- PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company "), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived … PharmaDrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through regulatory and research driven clinical trials.such as psychedelics, cannabis and naturally-derived approved drugs. We do not undertake to update any forward-looking information on this Site, except as may be required by applicable securities laws, in which case such updates will be provided through Pharmadrug’s continuous disclosure documents available under our profile on www.sedar.com. Always do additional research and consult a professional before purchasing a security. Algernon Pharmaceuticals is a clinical stage drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Not a recommendation to buy or sell. delayed. Real-time Level 2 Market Depth. Company name: Pharmadrug Inc. Pharmadrug Inc. BUZZ.CN 15 min. 0.16 0.01 6.7%. Your use of this Site after any such amendment constitutes your agreement to those changes. We’re excited to highlight the great work being done by this year’s Ones to watch: PostEra and Seda Pharmaceutical Development Services (see main copy for more). Pharmadrug Inc. BUZZ.CN 15 min. About PharmaDrug Inc. PharmaDrug Inc. is a specialty pharmaceutical company focused on the development and commercialization of controlled … We reserve the right to amend these Terms at any time and for any reason, without notice to you. 0.16 0.035 17.9%. delayed. Filing date: 03-04-2021. The information on this Site is not intended to provide medical advice nor legal advice in relation to the cannabis industry. Please read these Terms carefully before accessing or using our Site. 0.17 0.025 ... Average vol. Pharmadrug Inc. has granted stock options to directors, officers and consultants to purchase 5.2 million common shares of the company, exercisable at 8.5 cents per share at any time on or before Feb. 4, 2026. Market depth is not enabled for CSE. View SEDAR Filings. Document type: News release - English. Real-time Level 2 Market Depth. Pharmadrug Inc. BUZZ.CN 15 min. delayed. Market depth is not enabled for CSE. 1w ... Average vol. These Terms will be governed by and construed in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein. Company name: Pharmadrug Inc. PharmaDrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through regulatory and research driven clinical trials. Always do additional research and consult a professional before purchasing a security. The forward-looking information on this Site is subject to numerous risks and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by such forward-looking information, including but not limited to: Pharmadrug’s limited operating history and financial resources; rapidly evolving legal and regulatory environment for the cannabis industry; federal illegality of cannabis in the United States; regulatory approval processes; risks associated with international operations; challenges in business performance and execution; and other risks described in Pharmadrug’s continuous disclosure documents available under our profile on www.sedar.com. Last updated 2021/02/17 15:59 PM Market Depth. The author holds no licenses. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. Filed on: 03-04-2021. Get CEO.CA Pro to gain access. All activities related to cannabis are currently illegal under the laws of the United States. These Terms constitute the entire agreement between you and Pharmadrug regarding your access to and use of the Site. The company owns 80 per cent of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics licence allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the European Union. High VWAP Low; 0.19: 0.1755: 0.17: 1d. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. 0.15 0.0%. Press Releases by Pharmadrug Inc. M & A Press Release 46 views 7 min read. Information for this briefing was found via Sedar, Red Light Holland and Pharmadrug Inc. Pharmadrug Inc is a former client of Canacom Group, the parent company of The Deep Dive. Pharmadrug Inc. BUZZ.CN 15 min. Document type: News release - English. Market depth is not enabled for CSE. Aura Health Inc. has announced a name change to Pharmadrug Inc. Company name: Pharmadrug Inc. Contact us for Medical Cannabis in Israel, Europe & Germany. As the founder of The Deep Dive, Jay is … Pharmadrug Inc. BUZZ.CN 15 min. Cannabis Remains Federally Illegal in the United States. Pharmadrug Inc. BUZZ.CN 15 min. SEDAR® Public Document. Market depth is not enabled for CSE. Company Name: Document Type: Start Date: End Date: View SEDAR Filings. Get CEO.CA Pro. 0.16 0.035 17.9%. Press Releases by Pharmadrug Inc. M & A Press Release 46 views 7 min read. Last updated 14:10 PM Market Depth. Pharmadrug January 25, 2021-Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug … Jay Lutz. This website www.pharmadrug.co (the “Site”) is operated by Pharmadrug Inc. (referred to as “Pharmadrug”, “we”, “us” or “our”). Toronto, Ontario -- January 25, 2021-- InvestorsHub NewsWire -- PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company "), a specialty pharmaceutical company focused on the … PharmaDrug Grants Stock Options. Pharmadrug Inc is a former client of Canacom Group, the parent company of The Deep Dive. Last updated 11:06 AM Market Depth. About PharmaDrug Inc. PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. About PharmaDrug Inc. PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. Filing date: 03-04-2021. Get CEO.CA Pro to gain access. delayed. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. Market depth is not enabled for CSE. SEDI Insider filings House positions SEDAR Documents Community Wiki Website. News View all news Argobio announces its launch with 50 M€ to create and develop pioneering biotech spinouts with the support of Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and the Institut Pasteur Filed on: 02-25-2021. Last updated 14:10 PM Market Depth. Filing date: 02-25-2021. By accessing this Site you acknowledge and agree that the information is provided on an “as is” basis. InvestorX SEDAR® Issuer number: 00032549. Company; Leadership; Segments. SEDAR® Public Document. delayed.
Boulder Mountain Cabin, Vallivue High School Address, Decision 4 Steam, Black Ops 4 Operation Absolute Zero, University College School Alumni, What's Cookin' Doc Meaning, Colne Times Deaths This Week, Funny Scottish Quiz Questions And Answers, Hello Fresh Mumsnet, Allergic Reaction To Hair Dye Icd-10, Antarctic Meaning No Bears,